Filing Details
- Accession Number:
- 0001437749-19-024638
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-18 21:07:03
- Reporting Period:
- 2019-12-16
- Accepted Time:
- 2019-12-18 21:07:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1158895 | Lemaitre Vascular Inc | LMAT | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1365733 | Jr P Joseph Pellegrino | C/O Lemaitre Vascular, Inc. 63 Second Avenue Burlington MA 01803 | Chief Financial Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-12-16 | 6,068 | $36.17 | 41,491 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-12-18 | 10,442 | $36.10 | 31,049 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan established by the Reporting Person.
- The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $36.00 to $36.40. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
- The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $36.00 to $36.35. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
Billionaire Hedge Funds
